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Abstract
Background: Cranial radiotherapy is used to treat tumors of the central nervous system (CNS), as well as non-
neoplastic conditions such as arterio-venous malformations; however, its use is limited by the tolerance of adjacent
normal CNS tissue, which can lead to devastating long-term sequelae for patients. Despite decades of research, the
underlying mechanisms by which radiation induces CNS tissue injury remain unclear. Neuroinflammation and
immune cell infiltration are a recognized component of the CNS radiation response; however, the extent and
mechanisms by which bone marrow-derived (BMD) immune cells participate in late radiation injury is unknown.
Thus, we set out to better characterize the response and tested the hypothesis that C-C chemokine receptor type 2
(CCR2) signaling was required for myeloid cell recruitment following brain irradiation.
Methods: We used young adult C57BL/6 male bone marrow chimeric mice created with donor mice that
constitutively express enhanced green fluorescent protein (eGFP). The head was shielded to avoid brain radiation
exposure during chimera construction. Radiation dose and time response studies were conducted in wild-type
chimeras, and additional experiments were performed with chimeras created using donor marrow from CCR2 deficient,
eGFP-expressing mice. Infiltrating eGFP+ cells were identified and quantified using immunofluorescent microscopy.
Results: Brain irradiation resulted in a dose- and time-dependent infiltration of BMD immune cells (predominately
myeloid) that began at 1 month and persisted until 6 months following ≥15 Gy brain irradiation. Infiltration was limited
to areas that were directly exposed to radiation. CCR2 signaling loss resulted in decreased numbers of infiltrating cells
at 6 months that appeared to be restricted to cells also expressing major histocompatibility complex class II molecules.
Conclusions: The potential roles played by infiltrating immune cells are of current importance due to increasing
interest in immunotherapeutic approaches for cancer treatment and a growing clinical interest in survivorship and
quality of life issues. Our findings demonstrate that injury from brain radiation facilitates a dose- and time-
dependent recruitment of BMD cells that persists for at least 6 months and, in the case of myeloid cells, is
dependent on CCR2 signaling.
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Background
Cranial radiotherapy is frequently utilized as part of the
treatment of primary and secondary brain tumors, pro-
phylaxis against clinically occult systemic malignancies,
and for non-neoplastic diseases, such as arterio-venous
malformations. However, the use of curative doses of radi-
ation is often limited due to the potential for damage in
the adjacent and surrounding normal brain tissue. Indeed,
both acute and late/delayed radiation-induced sequelae
can result in significant morbidity and/or mortality for pa-
tients, and thus, the pathogenesis of radiation injury in the
normal central nervous system (CNS) tissue has been the
subject of investigation for decades. Unfortunately, a thor-
ough understanding of the underlying mechanisms, lead-
ing to mitigation strategies, has remained elusive.
Although identified as a frequent constituent of acute
and late effects seen following radiation exposure, the
precise contribution of neuroinflammation to their initi-
ation and progression in the brain is not entirely clear.
Work from our group [1–3] and others [4–6] has sug-
gested a critical role for inflammation in the normal
CNS response to radiation. Furthermore, use of anti-
inflammatory therapies, such as post-therapy steroids
and NSAIDs, has demonstrated some beneficial out-
comes, both in preclinical studies [7–9] and in patients
[10–12]. However, the complex interplay between the
various components of the inflammatory and immune
systems has limited the ability of researchers to identify
more specific targets that could effectively mitigate CNS
normal tissue effects. For example, our group previously
demonstrated acute and persistent increases in the num-
bers of CD3+ cells and CD11c+ cells in the CNS, as well
as increased expression of MHC II, in response to radiation
[3]. However, the development of specific and targeted
therapeutic approaches would require identification of the
origin of these CD11c+ and MHC II+ cells, since both pop-
ulations could originate either from endogenous microglia
or from leukocytes that have infiltrated from the periphery.
Multiple laboratories have investigated leukocyte infil-
tration in the CNS and have shown that bone marrow-
derived cells have the ability to enter and persist within
the CNS, with a tremendous potential for transformation
[13–22]. Importantly, the rate of leukocyte infiltration into
the CNS has been shown to increase in the setting of in-
flammation and injury [21, 23–27], and an intriguing
study, examining the infiltration of peripherally derived
immune cells using bone marrow transplanted animals,
suggested that leukocytes recruited to the CNS can de-
velop a dendritic cell phenotype [17], although there is de-
bate as to whether dendritic cells could also arise from
resident microglia [28–30]. Burrell et al. showed that cra-
nial irradiation led to a time- and dose-dependent infiltra-
tion of bone marrow-derived (BMD) cells, specifically in
areas directly exposed to the radiation beam, starting at
7 days and persisting for up to 1 month post-irradiation.
About 50 % of the BMD cells located in the brain paren-
chyma stained for the microglial marker Iba-1, 7 days fol-
lowing radiation [31]. Only a very small number of the
BMD cells were found to express smooth muscle cell
markers, and none were found to express endothelial or
other glial markers. It is unclear whether these cells per-
sisted later than 1 month post-radiation or if they contrib-
ute to the CD11c+ cells we previously reported [3].
Recruitment of myeloid lineage cells into the injured
CNS environment depends on the expression of endo-
thelial activation markers, such as intracellular adhesion
molecule-1 (ICAM-1) [32–34] and chemokine signaling,
particularly through the C-C (motif ) ligand-2 (CCL2)/C-
C chemokine receptor type 2 (CCR2) [35–37] and stro-
mal cell-derived factor (SDF1)/CXCR4 pathways [38, 39].
The ICAM-1 and CCL2/CCR2 pathways have also been
shown to play a role in the recruitment of dendritic
cells into injured/inflamed tissues, including the brain
[35, 40–43]. Significantly, previous studies from our la-
boratory have demonstrated increased messenger RNA
(mRNA) levels of CCL2 and ICAM-1 following CNS radi-
ation exposure at times as late as 6–12 months post-
irradiation [3, 33]. A recent study by Morganti et al.
demonstrated an increase in the number of CD11b+/F4-
80+/CX3CL1-/CCR2+ cells (assumed to be peripherally
derived), a significant increase in the CCL2 protein level,
and an increase in the ICAM-1 mRNA level in the brain
at 7 days following 10 Gy of cranial irradiation, suggesting
that CCR2 signaling is responsible for the recruitment of
these cells [44]. Taking all these findings together, we have
hypothesized that the time-dependent appearance of
MHC II+ and CD11c+ cell populations observed follow-
ing mouse brain irradiation in our previous work [3] is
dependent on CCL2/CCR2 signaling.
To address this hypothesis, bone marrow chimera ani-
mals were created using marrow from animals engineered
to constitutively express enhanced green fluorescent pro-
tein (eGFP) under the β-actin promoter and, following
confirmation of chimerism, the animals underwent brain
irradiation. In support of our hypothesis, radiation expos-
ure resulted in a chronic, dose-dependent increase in the
number of eGFP-expressing cells in the brain. Further-
more, chimeras created with CCR2-deficient, eGFP+ bone
marrow demonstrated reduced infiltration levels of eGFP+
myeloid cells following CNS radiation, indicating the im-




This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health.
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Animal protocols were reviewed and approved by the Uni-
versity of Rochester Institutional Animal Care and Use
Committee (Protocol Number: 2004-74). Male C57BL/6J
(stock no. 000664), C57BL/6-Tg(CAG-EGFP)10sb/J (stock
no. 003291), and B6.129S4-Ccr2tm1Ifc/J (stock no. 004999)
mice were purchased from The Jackson Laboratory at 8 to
10 weeks of age. Animals were housed 5 to a cage in
temperature (23 ± 3oC) and light (12:12 light/dark) con-
trolled rooms with free access to chow and water. Mice
were routinely monitored for health issues and had no ob-
servable problems at the time of euthanasia.
Bone marrow chimeras
C57BL/6J mice were exposed to two 6 Gy doses of
whole body irradiation, separated by 4 h, using a 137Cs
source (J. L. Shepherd and Assoc.) at a dose rate of
1.9 Gy/min. The mice were unanesthetized, confined in
customized plexiglass jigs, and placed on a slit collima-
tor such that the radiation field included the entire
mouse, with the head shielded in order to reduce the
dose to the head to 15–20 % of the unshielded area.
Head shielding was used in order to minimize the split
dose effect with respect to the subsequent brain expo-
sures since we observed significant increases in the
number of eGFP+ cells in the CNS of non-shielded ani-
mals compared to head-shielded animals following brain
irradiation (Additional file 1: Figure S1). Indeed, other
investigators also have found increased immune cell in-
filtration in bone marrow transplanted animals where
the cranium was exposed to radiation as part of the
transplantation process [26, 45]. Following the second
dose of total body radiation, the mice were injected
intravenously with 4 × 106 bone marrow cells harvested
from the femurs and tibias of mice that constitutively
express enhanced green fluorescent protein (eGFP) and
then returned to the vivarium for 6 weeks, allowing for
bone marrow reconstitution. To determine the role of
CCR2 signaling, we used an identical procedure to create
chimeric C57BL/6J mice reconstituted with bone marrow
from eGFP-expressing mice that had been crossed with
mice deficient for CCR2. In all studies, the degree of bone
marrow reconstitution was confirmed by drawing periph-
eral blood prior to euthanasia. Flow cytometry was subse-
quently performed to confirm the percentages of eGFP+
cells expressing CD11b, B220, CD4, and CD8, represent-
ing monocytic, B cell, and T cell lineages, respectively.
Brain irradiation
For brain irradiation, mice were anesthetized (ketamine
[90 mg/kg] and xylazine [8 mg/kg], administered intra-
peritoneally) then laid supine on the 137Cs irradiator
such that the brain volume between their eyes and ears
was exposed using a 5-mm × 12.2-cm collimator slit.
This collimator provided a uniform field at a dose rate
of 1.25 Gy/min with sharp edges that fell to a dose rate
of 0 Gy/min within 2.5 mm of the slit edge. Animals (n =
6 per group) were exposed to a dose range of 0 to 45 Gy.
After irradiation, mice were returned to the vivarium and
supplied with laboratory diet and water ad libitum until
the time of euthanasia. Mice in the time course study
(35 Gy only) were euthanized at 1 day, 3 days, 7 days,
1 month, 3 months, or 6 months post-radiation; mice in
the dose range and CCR2 chimera studies were eutha-
nized at 6 months post-radiation.
Tissue collection
Immediately after euthanasia, mice were flushed intracar-
dially with 10–15 ml of a solution containing 2 IU/ml hep-
arin and 0.05 % sodium nitrite in 0.15 M phosphate buffer
(PB) and then perfused with 50 ml of 4 °C 4 % paraformal-
dehyde dissolved in 0.15 M PB (pH = 7.2). Brains were re-
moved and post-fixed in 4 % paraformaldehyde dissolved
in 0.15 M PB (pH = 7.2) at 4 °C for 2 hours protected from
light. Brains were then transferred to a 30 % sucrose solu-
tion in 0.15M PB at 4 °C, protected from light until equili-
brated, and were then snap frozen in isopentane and
stored at −80 °C until sectioning.
Immunohistochemistry/immunofluorescence assays
Brains were sectioned in the coronal plane at 30 μm on
a sliding knife microtome with a −25 °C freezing stage.
Sections were stored in cryoprotectant at −20 °C until
further processing. Visualization of antibody-bound sec-
tions for immunohistochemistry (IHC) was performed
using biotinylated secondary antibodies, avidin-biotin
complex (Elite), and 3,3-diaminobenzadine (DAB) sub-
strate kit (Vector Laboratories). The following primary
antibodies were utilized: mouse MHC class II I-Ab (BD
Pharmingen, 1:2000); Iba-1 (Wako, 1:5000); ICAM-1 (AbD
Serotec, 1:2000); rat anti-CD3 (AbD Serotec, 1:4000); ham-
ster anti-CD3 (Santa Cruz Biotechnology Inc., 1:2000);
CD11c (BD Pharmingen, 1:500); and CD11b (Invitrogen,
1:1000). Biotinylated secondary antibodies utilized included
goat anti-Armenian hamster IgG (Jackson Laboratories,
1:1000); goat anti-mouse F(ab′)2 (Jackson Laboratories,
1:2000); goat anti-rabbit IgG (Vector Laboratories, 1:1000);
and goat anti-rat IgG (Vector Laboratories, 1:2000). Sec-
tions used for MHC II, CD11c, CD3, and Iba-1 analysis
were counterstained with Methyl Green (Vector Labora-
tories) according to the manufacturer’s protocol. For im-
munofluorescence, primary antibodies were utilized at
concentrations three times the IHC level. Secondary anti-
bodies bound to Alexa (Invitrogen) or DyLight (Jackson La-
boratory) fluorophores were utilized at a dilution of 1:500.
Cell quantification
Profiles of eGFP+ cells were quantified in three distinct
brain regions: the fimbria/fornix, corpus callosum/extreme
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capsule, and hippocampus, regions that were completely
within the radiation field. Counting for this analysis began
rostrally with the first section where the dentate gyrus was
visible and ceased caudally with the last section containing
the hippocampus. For the construction of the graph
demonstrating the distribution of eGFP+ cells along the
rostro-caudal axis (Fig. 3), eGFP+ cell profiles were
counted on sections throughout the brain until the end of
the cerebral cortex for each animal. In both of the afore-
mentioned cases, bright-field images of the sections were
captured using a RT Spot camera (Diagnostic Instru-
ments, Inc.) using a ×10 objective and were combined
using the photomerge function in Adobe Photoshop CSII
(Adobe Systems). Total areas for the regions examined
were calculated using ImageJ (NIH), and the total number
of cell profiles was divided by the total area in square mil-
limeters. In the case of Fig. 3, the number of cells per
square millimeter was plotted versus the approximate
distance to/from bregma, which was estimated using a
mouse brain atlas [46].
To quantify MHC II+, CD11c+, and CD3+ cells, sec-
tions were viewed with a Zeiss Axioplan2i light micro-
scope (Zeiss, Thornwood, NY, USA) and the numbers of
positively stained cells with a methyl green-stained nu-
cleus were derived from the total seen in the first two
brain sections containing the dentate gyrus. The total
number of MHC II+, CD11c+, and CD3+ stained cell pro-
files co-localizing with a methyl green positive nucleus
were also plotted for each time point. A two-way ANOVA
was conducted on the values associated with each marker
from both chimera animals and non-chimera animals at
6 months post-brain irradiation. When the interaction
term of the two-way ANOVA was significant, Fisher’s pro-
tected least significant differences post hoc tests were con-
ducted comparing all groups.
To quantify Iba-1+ cells in the hippocampus, sections
were viewed with a Zeiss Axioplan light microscope
equipped with a Prior motorized stage. Morphometric
data were collected using the stereological program
Stereologer (Systems Planning and Analysis, Inc.) and its
optical disector method for unbiased cell counting. The
number of cells was reported as the total number of Iba-
1-positive hippocampal cells. Data were compared by an
unpaired t test using Prism 5.01 (GraphPad Software,
www.graphpad.com). A p value <0.05 was considered to
be statistically significant.
Results
Chimera creation did not affect the peripheral or CNS
response to brain irradiation
In order to determine any effect of, or interaction be-
tween, chimera induction and subsequent brain irradi-
ation on circulating BMD cell populations, peripheral
blood was collected at all time points and analyzed using
FACS. The percentage of cells expressing CD11b, B220,
CD4, or CD8 (representing monocytic, B cell, and T cell
lineages, respectively) and also expressing eGFP were
calculated and were compared for each cell marker using
a two-way ANOVA with Bonferroni post hoc tests. No
significant difference in the interexperimental degree of
chimerism (relative levels of bone marrow reconstitution)
was seen between chimera groups alone or, importantly,
between brain-irradiated versus non-brain-irradiated chi-
meras at any of the different time points for the majority
of cell types (data not shown). The only exception was the
CD4+ population at 3 days post-brain irradiation, when a
significant, but transient, decrease in the percentage of
eGFP+ cells was seen (p < 0.01). The transience of this re-
sponse, likely an indicator of the known radiation sensitiv-
ity of CD4+ cells, was felt to be insufficient to affect the
responses seen at the remaining time points.
In addition to assessing the peripheral/humoral re-
sponse to chimera induction, IHC staining was performed
to determine whether the inflammatory responses seen in
the brains of chimeras were similar to that seen in wild-
type, non-chimera animals. Staining for MHCII, CD3, and
CD11c was conducted on control and 35-Gy-irradiated
tissues at 6 months post-bone marrow transplant (Fig. 1).
The numbers of positively stained cells for each marker in
transplanted wild-type animals were compared to the
numbers attained from non-transplanted wild-type ani-
mals using a two-way ANOVA. If the interaction term
was significant, it was followed by Fisher’s PLSD post hoc
tests.
For both MHC II+ and CD3+ cells, the two-way
ANOVA revealed no significant interaction between
brain irradiation and bone marrow transplant/chimera
induction (Fig. 1a, b), although a significant effect of bone
marrow transplantation on MHC II+ cells (F(1, 16) =
6.429, p = 0.0220) was found (Fig. 1a). Both MHC II+ and
CD3+ cells demonstrated a significant effect of brain ir-
radiation (F(1, 16) = 263.026, p < 0.0001; F(1, 17) = 26.45,
p < 0.0001, respectively), but the fact that there was no sig-
nificant difference between the number of MHC II+ or
CD3+ cells in animals undergoing chimera induction
followed by brain irradiation versus those undergoing
brain irradiation alone suggests little to no additive effect
from chimera induction.
Statistical analysis of CD11c+ cell numbers revealed a
significant effect from the chimera induction/BMT
protocol (F(1, 16) = 13.42, p = 0.002), a significant effect
of brain radiation exposure (F(1, 16) = 37.99, p < 0.0001),
and also a significant interaction effect (F(1, 16) = 9.369,
p = 0.0075) (Fig. 1c). However, since the number of CD11c+
cells was significantly different between the chimera/BMT
and non-chimera control groups, the fold change in
CD11c+ cells was calculated for irradiated mice with re-
spect to their controls for both conditions to determine
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whether the CD11c response to brain irradiation differed
between the two sets of animals. An unpaired t test found
that the fold change in the number of CD11c+ cells fol-
lowing brain irradiation between non-chimera (M = 17.7,
SD = 2.87) and chimera animals (M = 12.69), t(9) = 1.469,
p = 0.1760) did not reach statistical significance, support-
ing our contention that the irradiation component of
chimera induction did not affect the overall cell response
to brain irradiation.
Brain irradiation induced dose-dependent, delayed
infiltration of bone marrow-derived cells
To provide a detailed characterization of the effect of
CNS irradiation on the observed recruitment of periph-
erally derived immune cells to the brain, chimeras were
administered brain irradiation (0 or 35 Gy) and sacri-
ficed at multiple time points. Initial observation of tis-
sues showed no evidence of eGPF+ cell infiltration at
early time points, but clear evidence of infiltration at
later time points (Fig. 2a, b). Images were constructed to
illustrate the distribution of recruited cells at these later
time points (Fig. 2c), similar to our previously reported
findings [3]. Based on these findings, the number of
eGFP+ cells per square millimeter was quantified across
all time points for three distinct brain regions, two white
matter and one gray matter: (1) the fimbria/fornix, (2)
corpus callosum and extreme capsule, (3) and hippocam-
pus, respectively (Fig. 2d). At 1 month post-radiation, an
increase in the numbers of cells per square millimeter was
seen in all brain regions, although statistical significance
was only achieved in the hippocampal region (45 ± 40 vs.
1 ± 1, p < 0.01). However, by 3 months post-radiation, a
statistically significant increase in the number of eGFP+
cells per square millimeter was seen in all brain regions,
with the density increasing further at 6 months (Fig. 2d).
The data were analyzed using two-way ANOVA with
Bonferroni post hoc tests comparing brain-irradiated
chimeras to controls at each time point. Significant effects
of brain radiation exposure (p = 0.001, p < 0.0001, and p <
0.0001), effects of time (age post-radiation) (p = 0.005, p <
0.0001, and p < 0.0001), and effects of interaction between
brain irradiation and time (p = 0.007, p < 0.0001, and p <
0.0001) were found in the fimbria/fornix, corpus callo-
sum/extreme capsule, and hippocampal regions, respect-
ively. Interestingly, the majority of eGFP+ cells observed
exhibited microglial morphology, and the infiltration pat-
tern showed a rostro-caudal distribution, with little evi-
dence of infiltration in the extreme rostral or caudal
sections.
To determine the effect of dose on infiltration, the
study was repeated using a range of brain irradiation
doses (5–45 Gy). At 6 months post-radiation, the num-
ber of eGFP+ cell per square millimeter was again quan-
tified for the three brain regions and analyzed using
one-way ANOVA with Bonferroni post hoc tests, and
comparisons were performed between all doses (Fig. 2e).
Significant differences in the number of infiltrating cells
were found with respect to radiation dose in the fimbria/
fornix region (F(5, 24) = 14.77, p < 0.0001), the corpus
callosum/extreme capsule region (F(5, 24) = 20.16,
p < 0.0001), and the hippocampus (F(5, 24) = 13.22,
p < 0.0001). Post hoc test analysis revealed that brain
irradiation resulted in dose-dependent increases in cell
infiltration in all brain regions, which reached signifi-
cance ≥25 Gy, although infiltration was clearly evident
at 15 Gy (Fig. 2e).
Direct radiation exposure is required for peripherally
derived immune cell recruitment into CNS
As is often recognized clinically, the radiation-induced
injury seen in this study, defined by upregulation of acti-
vation and immune markers, areas of increased staining
and altered morphology, was limited to the tissue vol-
ume directly exposed to the radiation beam. This pattern
Fig. 1 IHC analysis of immune cell markers in eGFP chimeras at 6 months following brain irradiation. To determine if the radiation component of
chimera induction altered the presence of immune markers seen following brain irradiation in wild-type animals, 0- and 35-Gy brain-irradiated
eGFP chimera (bone marrow transplant: eGFP-BMT) and non-chimera (Non-Trans) animals were analyzed for a MHCII+, b CD3+, and c CD11c+
cells at 6 months post-irradiation. The numbers of positively stained cells quantified in the first two sections containing the dentate gyrus as
described in the Methods section were compared using a two-way ANOVA with Fisher’s protected least significant (PLSD) post hoc tests comparing all
conditions. Graph bars represent mean ± SEM, n = 4–6 mice per condition: **p≤ 0.01 and ***p≤ 0.001
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Fig. 2 Brain irradiation induced delayed, dose-dependent infiltration of bone marrow-derived cells. Chimera mice with bone marrow-expressing
eGFP received brain irradiation (0 or 35 Gy) and were sacrificed at multiple time points. Sections from irradiated mice at a 1 day and b 6 months
post-irradiation were stained with Hoechst solution, and photomicrographs were taken of the internal capsule. Scale bars: 100 μm. c Images
illustrating the distribution of eGFP+ cells at 6 months were constructed for 0 and 35 Gy animals. Each dot represents one eGFP-expressing cell.
d eGFP+ cells per square millimeter were quantified in three brain regions (the fimbria/fornix, corpus callosum/extreme capsule, and the
hippocampus), beginning with the first section caudal to bregma containing fimbria or fornix. Data were analyzed by two-way ANOVA and
Bonferroni post hoc tests comparing irradiated animals to controls for each time point, n = 4–5 mice per condition: **p≤ 0.01 and ***p≤ 0.001.
e Chimera animals were irradiated with 0, 15, 25, 35, or 45 Gy to brain, sacrificed at 6 months post-irradiation and analyzed for eGFP+ cells per
square millimeter. Data were analyzed by one-way ANOVA and Bonferroni post hoc tests comparing all of the doses, n = 4–5 mice per condition.
Symbols used to distinguish statistical significances between doses: *0 Gy, + 15 Gy, and #25 Gy. One symbol represents p≤ 0.05, two symbols
represent p≤ 0.01, and three symbols represent p≤ 0.001
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of response appeared to be repeated with respect to in-
flammatory cell infiltration since the rostral striatum,
which was shielded by the irradiator collimator, failed to
demonstrate cellular infiltration at any dose compared
to the internal capsule, which was within the radiation
beam (Fig. 3a). To better establish whether the directly
injured tissue selectively influenced the influx of periph-
erally derived immune cells, a profile of eGFP+ cells was
established from a 1:24 series of brain tissue sections
from 0- or 45-Gy-irradiated animals. The number of
cells per square millimeter was plotted versus the loca-
tion relative to bregma of the quantified tissue section
(Fig. 3b); locations were estimated using a mouse brain
atlas [46]. In the control (non-brain irradiated) chimera
animals, the number of cells per square millimeter did
not change significantly between tissue sections along
the rostro-caudal axis, regardless of position in relation
to bregma. Furthermore, the quantification of tissue sec-
tions from non-irradiated chimeras indicated only ≤3
eGFP+ cells per square millimeter. In contrast, sections
from 45-Gy brain-irradiated chimera animals exhibited a
greater range of values (1–121 cells/mm2), with every
animal assessed exhibiting a similar pattern regarding
cell number change (increase, plateau, then decrease)
along the rostro-caudal axis. Although the position of
the peak response varied along the axis, the distance
over which the change in cell numbers occurred was ob-
served as being relatively similar (within approximately
7–8 brain sections). To confirm this observation, Fig. 3b
was re-plotted, using the tissue section that showed the
greatest infiltrate per square millimeter as section 0
(Fig. 3c). Since the sections were cut at 30-μm intervals
and mounted 1:24, multiplying the number of sections
over which the number of eGFP+ cells was greater than
that of controls yielded a radiation-responsive distance
of 5.04–5.76 mm, relatively close to the anticipated vol-
ume of radiation injury from a 5-mm slit, the exact size
of the collimator utilized in our model, plus the add-
itional injury due to Bremsstrahlung radiation.
Bone marrow-derived cells express CD11c, MHC II, CD11b,
and CD3 in irradiated brain
To further characterize radiation-induced myeloid cell
recruitment and determine their contribution to the
observed neuroinflammatory response, sections from
chimera animals exposed to 0 versus 35 Gy brain irradi-
ation at six months post-radiation were stained for eGFP
and the immune marker, CD11b. Visual examination re-
vealed that a large proportion of the eGFP+ cells co-
labeled with CD11b, indicating recruitment of cells of
Fig. 3 Distribution of eGFP+ cells along the rostro-caudal axis. Chimera mice with bone marrow constitutively expressing eGFP received brain
irradiation (0 or 45 Gy) and were sacrificed at 6 months post-radiation. a Sections taken 1:24 were stained with Hoechst solution, and
photomicrographs of the striatum and internal capsule for both control and irradiated mice were taken. Scale bars: 100 μm. b The number of
eGFP+ cells per square millimeter was plotted in relation to the estimated distance from bregma (mm) in 0- and 45-Gy brain-irradiated animals.
c The number of eGFP+ cells per square millimeter in 45-Gy brain-irradiated chimera mice was plotted in relation to the section containing the
peak infiltrate of eGFP+ cells
Moravan et al. Journal of Neuroinflammation  (2016) 13:30 Page 7 of 15
myeloid origin (Fig. 4a), although independent staining
for MHC II, CD3, and CD11c confirmed the recruitment
of infiltrating cells of multiple phenotypes into the brain
parenchyma (Fig. 4b–d), as was reported in our previous
study [3]. To determine any interaction between these
various cell populations, additional co-localization stud-
ies were performed (Fig. 5). Cells co-expressing eGFP
with MHC II and CD11c were seen adjacent to cells ex-
pressing MHC II and CD11c only, suggesting that the
inflammatory population was comprised of both en-
dogenous and peripheral cells.
Based on the cell profile density, the average number
of infiltrating cells in the hippocampus at 6 months
post-radiation was calculated to be ~34.3 × 103 cells. To
determine if this recruitment resulted in an increase in
the total number of myeloid cells, sections from 0 and
45 Gy exposed animals at 6 months post-radiation were
stained for Iba-1 and the number of Iba-1+ cells in the
hippocampus was quantified using unbiased stereology.
Although there was a clear difference in morphology
and staining intensity between control and irradiated tis-
sues (Fig. 6a), an unpaired t test revealed no significant
Fig. 4 Characterization of infiltrating immune cells. Sections from 35 Gy brain-irradiated, eGFP+ chimera animals at 6 months post-radiation were
stained for a CD11b, b CD3, c MHC II, or d CD11c. Scale bars: a, b 20 μm, c 30 μm, and d 50 μm
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difference in the total number of microglial/myeloid cells
between brain-irradiated animals and controls in the
hippocampus at this time point (Fig. 6b), suggesting that
the infiltrating cells had replaced, but not added to, the
population of microglial resident cells.
Radiation-induced recruitment of peripherally derived
myeloid cells is dependent on CCR2 signaling
As noted, we had observed that the majority of infiltrat-
ing cells following brain irradiation appeared to display a
microglia- or myeloid-like morphology (Figs. 5 and 6).
CCR2 is a chemokine receptor recognized as playing a
critical role in the recruitment of monocyte cells in vari-
ous disease models [47]. Previous work from our labora-
tory demonstrated early and late increases for CCR2’s
primary ligand, CCL2 (MCP-1) [1, 3]. To examine the
role of CCL2/CCR2 signaling in immune cell recruit-
ment seen following brain irradiation, animals deficient
for CCR2, but constitutively expressing eGFP under the
β-actin promoter, served as donors for chimera studies.
Following confirmation of chimerism, animals were ex-
posed to 0 or 35 Gy brain irradiation and sacrificed at
6 months post-irradiation. The numbers of eGFP+ cells
in the eGFP+ CCR2-null chimeras were quantified in
the three regions of interest in the brain and compared
to eGFP+ CCR2+ animals utilizing two-way ANOVAs,
followed by Fisher’s PLSD post hoc tests comparing all
groups (Fig. 7a). Importantly, transplant efficiencies ana-
lyzed by two-tailed, unpaired t test for the eGFP+ CCR2-
null versus eGFP+ CCR2+ chimera animals showed no
significant difference in the percentage of eGFP+ CD45+
cells in peripheral blood between the two sets of trans-
planted animals.
Analysis of area-specific infiltrating (eGFP+) cells in
the eGFP+, CCR2-null chimeras at 6 months post-
radiation (Fig. 7a) showed a significant interaction effect
(F(1, 17) = 5.15, p = 0.04; F(1, 17) = 43.69, p < 0.0001; F(1,
17) = 17.24, p = 0.0007) and a significant effect of brain
irradiation F(1, 17) = 41.56, p < 0.0001; F(1, 17) = 73.83,
p < 0.0001; F(1, 17) = 30.30, p < 0.0001) in the fimbria/
fornix, corpus callosum and extreme capsule, and hippo-
campus, respectively, as would be anticipated, but also
demonstrated a significant effect of bone marrow geno-
type (F(1, 17) = 6.61, p = 0.02; F(1, 17) = 46.08, p <
0.0001; F(1, 17) = 23.70, p = 0.0001). No significant dif-
ference in the number of eGFP+ cells per square
Fig. 5 Brain irradiation resulted in the recruitment of CD11c+/MHC II+ cells. Sections from 35 Gy brain-irradiated eGFP+ chimera animals at
6 months post-radiation were stained for MHC II and CD11c. Co-localization of markers were seen in eGFP-negative, endogenous cells (white ar-
rows) as well as eGFP+ peripherally derived cells (green arrows). Scale bars: 100 μm
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millimeter was found between CCR2+ and CCR2-null
0 Gy control animals in any of the regions of interest,
indicating that there was no baseline effect on recruit-
ment. However, post hoc test analysis showed a signifi-
cant difference in the number of eGFP+ cells per square
millimeter between genotypes in all areas of interest
(p = 0.05, 0.003, and 0.002 for the fimbria/fornix, cor-
pus callosum and extreme capsule, and hippocampus,
respectively) following irradiation, with a significant
decrease in the number of eGFP+ cells seen in all areas of
interest in the CCR2-null chimeras, suggesting that CCR2
signaling does indeed play a role in radiation-induced cel-
lular recruitment to the CNS (Fig. 7a).
To investigate whether CCR2 deficiency had a differ-
ential effect on the radiation-induced recruitment of the
specific immune cell types in the brain, tissue sections
from irradiated and control eGFP+ CCR2-null chimeras
were stained for CD3, CD11c, and MHC II, quantified
and compared to eGFP+ CCR2+ animals. Data were an-
alyzed by two-way ANOVA, followed by Fisher’s PLSD
post hoc tests comparing control and brain-irradiated
animals at 6 months post-radiation (Fig. 7b). Analysis of
the CD3+ cells demonstrated a significant effect of
radiation exposure (F(1, 15) = 49.93, p < 0.0001), but no
significant effect with respect to marrow genotype, sug-
gesting that radiation-induced T cell infiltration was in-
dependent of CCR2 signaling. Analysis of the number of
CD11c+ cells also showed a significant effect of brain ir-
radiation (F(1, 15) = 109.0, p < 0.0001) but no significant
interaction effect or effect of marrow genotype. How-
ever, using an unpaired, two-tailed t test with Welch’s
correction to compare the number of CD11c+ (resident)
cells to CD11c+ cells showing co-localization with eGFP
+ (BMD/recruited) revealed a significant reduction in
the number of recruited CD11c+ cells in the eGFP+
CCR2-null chimeras (M = 284.0, SD = 48.6) compared to
the eGFP+ CCR2+ chimeras (M = 773.5, SD = 164.4)
(t(4) = 2.856, p = 0.0461) despite the overall total num-
bers of CD11c+ cells remaining the same. These findings
strongly suggest that CCR2 signaling plays a role in the re-
cruitment of myeloid CD11c+ cells to the brain following
irradiation, but that, in the absence of CCR2 signaling,
compensatory mechanisms allow for amplification of the
resident microglial (CD11c+) population.
Analysis of the MHC II+ cells suggest that a slightly
different CCR2-related response was elicited in this cell
population, with a significant effect now being seen on
total cell numbers with respect to marrow genotype
Fig. 6 Stereologic quantification of hippocampal myeloid cells in 0 and 45 Gy brain-irradiated, eGFP+ chimera mice at 6 months post-irradiation.
a Sections from eGFP chimeras at 6 months following 0 or 45 Gy brain radiation were stained for Iba-1 and counterstained for methyl green
(Vector Laboratories). Scale bars: 100 μm; inset, 20 μm. b Graphical representation of the total number of Iba-1+ cells in the hippocampi of 0 and
45 Gy brain-irradiated chimeras. The average numbers of cells were compared using a two-tailed t test. Graph bars represent mean ± SEM, n = 6
mice per condition
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(F(1, 17) = 8.59, p = 0.009). Post hoc testing, using Fisher’s
PLSD, showed a significant decrease in the number of
MHC II+ cells following brain irradiation in the CCR2-
null chimeras (p = 0.0023) (Fig. 7b). In addition, further
analysis by unpaired, two-tailed t test with Welch’s correc-
tion again revealed a decrease in the number of MHC II+,
eGFP+ cells in the eGFP+ CCR2-null chimeras (M = 57.9,
SD = 18.9) relative to the eGFP+ CCR2+ animals (M =
381.8, SD = 40.9) (t(5) = 7.190, p = 0.0008). As had been
seen with respect to the CD11c+ cells, these findings sug-
gest that CCR2 signaling also plays a role in the recruit-
ment of MHC II+ cells to the brain following irradiation,
but that compensatory mechanisms allowing for amplifi-
cation of the resident MHC II+ population are less robust
in the absence of CCR2 signaling.
Discussion
Earlier work from our group [3] and others [17, 31] has
demonstrated that brain irradiation leads to delayed in-
flux of peripherally derived leukocytes in the CNS that
becomes apparent as early as 7 days post-irradiation.
Moreover, we demonstrated the persistence of peripher-
ally derived cells in the parenchyma out to 1 year post-
radiation [3]. In combination with the increased MHC II
expression noted in our previous experiment, these find-
ings led us to postulate that increased MHC II expres-
sion may result from radiation-dependent recruitment of
peripherally derived myeloid cells as reported by Burrell
et al. [31] and that infiltration of these cells is dependent
on CCR2 signaling, which has been shown to be import-
ant for myeloid cell recruitment in other models of CNS
injury [47].
The series of studies presented utilized bone marrow
chimeras. Use of this model may be felt by some to con-
found data interpretation since irradiation is part of the
induction process, adding an additional earlier radiation
injury; however, our use of head shielding during the
creation of chimeras appeared to effectively abrogate the
cell infiltration seen in chimeras created without head
shielding (Additional file 1: Figure S1). Moreover, the
few eGFP+ cells observed in our control chimeric mice
(0.5–3 cells/mm2) were nearly all associated with the
vasculature, which contrasts with the parenchymal loca-
tion of infiltrating cells observed following brain irradi-
ation. It also is possible that some of the differences seen
in the various cell populations may have been the result
of the transplantation process itself. However, there were
no significant differences between the infiltrative response
Fig. 7 Effect of CCR2 signaling on immune cell infiltration following brain irradiation. a eGFP+ CCR2-null chimeras were exposed to 0 or 35 Gy
brain irradiation and sacrificed at 6 months post-radiation. The numbers of eGFP+ cells per square millimeter were calculated for three regions of
interest (the fimbria/fornix, corpus callosum/extreme capsule, and hippocampus). Data were compared to eGFP+ CCR2-competent chimeras using
a two-way ANOVA and Bonferroni post hoc tests. b Sections from eGFP+ CCR2-null chimeras versus eGFP+ CCR2-competent animals were stained
immunofluorescently for CD3, MHC II, or CD11c. The number of positively stained cells also expressing eGFP was calculated for both the MHC II and
CD11c analyses: total numbers of CD11c+ or MHC II+ cells are represented by the red bars, cells co-localizing with eGFP are represented by the green
portion of the bars. All graph bars represent means ± SEM, n = 4–6 mice per condition: *p≤ 0.05, **p≤ 0.01, and ***p≤ 0.001. For the percent of posi-
tively stained cells that also expressed eGFP, +p≤ 0.05, +++p≤ 0.001
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of the various cell types to brain irradiation between
chimera and non-chimera animals, with the sole exception
of the CD11c+ population. With respect to that popula-
tion, chimeric animals were found to have increased
numbers of CD11c+ cells at baseline compared to non-
transplanted animals (Fig. 1c), supporting the observation
of a radiation-induced recruitment of CD11c+ cells from
the periphery made by Simard and Rivest [17], which in-
creased over time. In addition, the number of CD11c+
cells in the CNS has been shown to increase with normal
aging [30]. Although chimera animals in our study were
typically 6 weeks older than non-chimera mice (because
of the time required for bone marrow reconstitution), this
relatively small difference in their ages is unlikely to ac-
count for the difference observed in CD11c+ cell density
6 months after irradiation. Importantly, all remaining
comparisons were made between chimera groups.
Our studies demonstrated that radiation exposure of
the brain yielded a delayed dose-dependent infiltration
of peripherally derived cells that began at 1 month post-
irradiation and continued to 6 months (Fig. 2). The in-
creased numbers of peripheral cells accumulating in the
CNS with dose and time could be due solely to recruit-
ment or to a combination of recruitment and prolifera-
tion; future studies using proliferative markers could
help distinguish between these possibilities. Our tem-
poral findings are consistent with those of Burrell et al.
[31], although we were not able to demonstrate a signifi-
cant difference in cell number at 7 days. Infiltration oc-
curred at a brain radiation dose of 15 Gy, but not 5 Gy,
and is consistent with observations from other laborator-
ies showing bone marrow-derived cell infiltration in the
irradiated brain with 10 and 13 Gy [44, 48] as well as
our own experiments in unshielded chimera mice, which
showed infiltration with a cumulative dose of 12 Gy
(Additional file 1: Figure S1). Such doses are well within
the range used for normal tissue margins in stereotactic
radiosurgery [49, 50], but whether CNS infiltration of
peripheral cells occurs with fractionated radiotherapy
has not been investigated. The majority of infiltrating
cells presented with a microglial phenotype and stained
positively for CD11b, a marker of myeloid cells (Fig. 4a),
although positive staining for other immune cell markers
was also found on peripherally derived eGFP+ cells
(Fig. 4b–d). The relative expression of other inflamma-
tory markers in our study was similar to that seen by
others [31], with a majority of BMD cells recruited to
the CNS co-localizing with the myeloid markers CD11b,
MAC3, and Iba-1. Our study also demonstrated the
presence of cells staining positive for CD11c and MHC
II in the brains of chimera mice following irradiation
(Fig. 5). The majority of these cells were eGFP+, indicat-
ing that they were BMD. Because chimerism was incom-
plete, the degree to which endogenous CNS microglia
were also activated to express CD11c and MHC II could
not be determined.
The temporal pattern of leukocyte infiltration (Fig. 2)
is consistent with the pattern of T cell recruitment seen
in our previous study [3] and is similar to the pattern
observed by Burrell et al., although they detected in-
creased numbers of BMD cells as early as 7 days post-
irradiation [31], as had Morganti et al. [44]. Possible
explanations for the temporal discrepancy in infiltration
between those studies and the present study include the
use of different mouse strains, radiation doses, methods
of cell quantification, statistical analyses, and the interval
between bone marrow transplantation and cranial irradi-
ation. Nonetheless, our work provides additional evi-
dence that a component of the brain’s response to
radiation injury is an accumulation of myeloid cells from
the periphery that persists for up to 6 months.
Our finding that CCR2-deficient chimeras demon-
strated decreased BMD cell recruitment (Fig. 7) strongly
suggests that radiation-induced neuroinflammation leads
to myeloid cell recruitment via a CCL2/CCR2-dependent
mechanism. These findings are consistent with the results
in other models of CNS injury that have demonstrated the
importance of CCL2/CCR2 signaling for monocyte/
macrophage recruitment [47, 51]. However, it is possible
that the decrease in CNS infiltrating cells observed in the
CCR2-deficient chimeras was due to a reduction in circu-
lating inflammatory monocytes, since, in addition to its
established role in migration of hematopoietic stem cells
into tissues [40], CCR2 signaling also plays a role in mi-
gration of these cells out of the bone marrow [52, 53]. Fur-
ther experiments will need to be conducted to better
address this issue in the context of radiation injury.
Another possible explanation for the observed increase
in BMD cell recruitment is a lack of self-renewal by en-
dogenous microglial progenitor cells following radiation-
induced damage. Despite the infiltration of peripherally
derived cells following brain irradiation in this study, we
did not find a significant increase in the total number of
microglia in the hippocampus (Fig. 6). This is in contrast
to the findings of Okonogi et al. who demonstrated in-
creased numbers of Iba-1+ cells in the brain stem, basal
ganglia, and cerebral cortex at 3 and 8 weeks following
13 Gy of brain irradiation [48]. One explanation for dis-
crepancies between the two studies is that different brain
areas were analyzed; the variable myeloid response to ra-
diation in different brain regions has been described re-
cently in rats [54]. In addition, our analysis was limited
to counts at 6 months post-radiation, so it is possible
that there may have been earlier increases in cell num-
bers that were subsequently lost; the study by Okonogi
et al. only followed the animals out to 8 weeks post-
radiation [48]. Importantly, the overall density of BMD
cells in irradiated brain reported by Okonogi is similar
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to the density of BMD cells we observed, and they repre-
sent a modest fraction of all Iba-1 labeled cells in histo-
logical sections [48]. These findings contrast with results
reported by Burrell et al. who observed up to 50 % re-
placement of microglia by BMD cells in their study [31].
This discrepancy might relate to the detection method
utilized (two-photon microscopy). Further studies utiliz-
ing flow cytometry could be employed to better quantify
numbers of infiltrating cells as a function of dose, time
after irradiation, and brain region.
Conclusions
In summary, we have shown that peripherally derived
immune cells participate in the CNS response to radi-
ation, although their specific role is not clear. Certainly,
ample evidence exists for BMD cells playing important
roles in the repair of multiple forms of CNS injury, in-
cluding neurodegenerative disease [55–61]. These per-
ipherally derived cells may possess a more activated
phenotype and/or act as better phagocytes than en-
dogenous microglial cells in clearing debris or dysfunc-
tional molecules [17, 55]. We also demonstrated that
CCR2 signaling was required for the efficient recruit-
ment of myeloid cells to the CNS after irradiation. Inter-
estingly, CCR2 deficiency has been shown to prevent
hippocampal-dependent spatial learning and memory
impairment observed after cranial irradiation [62], rais-
ing the possibility that BMD infiltrating cells might con-
tribute to CNS dysfunction. However, other mechanisms
may underlie these deficits; for example, CCL2 deletion
improves recovery of neurogenesis following irradiation,
and this effect was not associated with dramatic cell in-
filtration at the times or conditions tested [63]. A better
understanding of the roles of BMD infiltrating cells and
the mechanisms behind their recruitment may provide a
means to exploit this phenomenon therapeutically to
prevent injury and treat associated CNS diseases.
Additional file
Additional file 1: Figure S1. Effect of head shielding during bone
marrow depletion on immune cell infiltration. In this bone marrow
transplant experiment, one set of animals experienced total body
exposure to two doses of 6 Gy, while the other set was irradiated with
head shielding. Both sets of animals were injected intravenously with 4 ×
106 eGFP-expressing bone marrow cells via the tail vein. Six weeks were
allowed for reconstitution, and then the animals were anesthetized
intravenously with a ketamine/xylazine (90 mg/kg/8 mg/kg) mixture and
brought down to the irradiator in a similar manner to those animals that
were cranially irradiated (sham irradiated). Animals were returned to the
vivarium and sacrificed at 6 months post-anesthetization. The numbers of
eGFP+ cells per square millimeter were calculated for the fimbria/fornix,
the corpus callosum/extreme capsule, and the hippocampus. The average
numbers of cells for section were compared using two-tailed t tests. HS =
Head Shielded; TBI = Total Body Irradiated. Graph bars represent means ±
SEM, n = 6 mice per condition: *p≤ 0.05, **p≤ 0.01, and ***p≤ 0.001.
(TIFF 2826 kb)
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